Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | USP14 | P54578 | 3/20 | 0.33 |
| ▸ | TDP2 | O95551 | 3/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 3/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | TDO2 | P48775 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.33 |
| ▸ | MAT2A | P31153 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18348434 | 1.00 | PTGER4 (0.35) | PTGER4NR3C1USP14TDP2HRH1 | |
| SCHEMBL18348376 | 1.00 | PTGER4 (0.35) | PTGER4NR3C1USP14TDP2HRH1 | |
| SCHEMBL18348387 | 1.00 | PTGER4 (0.35) | PTGER4NR3C1USP14TDP2HRH1 | |
| SCHEMBL21202493 | 0.99 | PTGER4 (0.36) | PTGER4NR3C1USP14TDP2HRH1 | |
| SCHEMBL21202423 | 0.99 | PTGER4 (0.36) | PTGER4NR3C1USP14TDP2HRH1 | |
| SCHEMBL18348438 | 0.96 | TDP2 (0.38) | PTGER4TDP2HRH1HTR6DUSP3 | |
| SCHEMBL18348426 | 0.96 | TDP2 (0.38) | PTGER4TDP2HRH1HTR6DUSP3 | |
| SCHEMBL18348375 | 0.96 | TDP2 (0.38) | PTGER4TDP2HRH1HTR6DUSP3 | |
| SCHEMBL18348369 | 0.96 | TDP2 (0.38) | PTGER4TDP2HRH1HTR6DUSP3 | |
| SCHEMBL21202490 | 0.94 | TDP2 (0.38) | PTGER4TDP2HRH1HTR6DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10367151-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20160380209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380209-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | PTGER4 402/4885NR3C1 387/4885USP14 3751/4885 |
| US-10367151-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | PTGER4 402/4885NR3C1 387/4885USP14 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.